APA Alıntı

Pollock, R. F., Valentine, W. J., Marso, S. P., Gundgaard, J., Hallén, N., Hansen, L. L., . . . Buse, J. B. (2018). DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK. Diabetes Ther.

Chicago Stili Alıntı

Pollock, Richard F., William J. Valentine, Steven P. Marso, Jens Gundgaard, Nino Hallén, Lars L. Hansen, Deniz Tutkunkardas, ve John B. Buse. "DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK." Diabetes Ther 2018.

MLA Alıntı

Pollock, Richard F., et al. "DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK." Diabetes Ther 2018.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..